Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma

This study has been completed.
Massachusetts General Hospital
University of Chicago
Information provided by (Responsible Party):
Pasi A. Janne, MD, PhD, Dana-Farber Cancer Institute Identifier:
First received: August 29, 2005
Last updated: December 23, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)